Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes. (Q45917429)
Jump to navigation
Jump to search
scientific article published on 28 July 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes. |
scientific article published on 28 July 2009 |
Statements
Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes (English)
Luca Maurillo
Alfonso Piciocchi
Paola Fazi
Giovanni Martinelli
Gina Zini
Maria Concetta Petti
Carlo Finelli
Enrico Pogliani
Giuseppe Fioritoni
Marco Gobbi
Lorenza Borin
Anna Di Tucci
Vincenzo Liso
Giuliana Alimena